![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/01/2906670/0/en/Solid-Biosciences-Joins-the-Russell-3000-Index.html
https://www.globenewswire.com/news-release/2024/07/01/2907076/0/en/Solid-Biosciences-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/06/04/2893411/0/en/Solid-Biosciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/15/2882333/0/en/Solid-Biosciences-Provides-First-Quarter-2024-Business-Update-and-Financial-Results.html
https://www.biospace.com/article/aav-manufacturing-takes-center-stage-at-asgct24/
https://www.globenewswire.com/news-release/2024/05/07/2876554/0/en/Solid-Biosciences-to-Present-at-the-American-Society-of-Gene-and-Cell-Therapy-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/05/02/2874663/0/en/Solid-Biosciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/04/03/2857343/0/en/Solid-Biosciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/04/01/2855112/0/en/Solid-Biosciences-Receives-Rare-Pediatric-Disease-Designation-from-the-FDA-for-Duchenne-Muscular-Dystrophy-Gene-Therapy-Candidate-SGT-003.html
https://www.globenewswire.com/news-release/2024/03/27/2853038/0/en/Solid-Biosciences-to-Participate-at-Cantor-s-Virtual-Muscular-Dystrophy-Symposium.html